Table 2.
Study | Year | Reasons for exclusion |
---|---|---|
Seidman et al. | 1991 | abstract only |
Seidman et al. | 1993 | abstract only |
Thomas et al. | 1992 | wrong outcome |
Thomas et al. | 1993 | no patient level data |
Breese et al. | 1995 | poor classification of steroid exposre |
Terrin et al. | 2002 | poor drug classification, no information on disease distribution |
Ruuska et al. | 1994 | wrong outcome, no discussion of randomization |
Soo et al. | 2013 | 80% of EEN group on AZA and 64% on 5-ASA, not a clean comparison of EEN vs. CS |
Saadah et al. | 2012 | combines data from EEN and CS arm, not a true comparator two armed study |
Gorard et al. | 2003 | adult population |
Mesker et al. | 2009 | no EN only comparator arm |
Zhu et al. | 2013 | adult population |
Hartmann et al. | 2008 | no EN only comparator arm |
Sigall-Boneh et al. | 2014 | no non-diet treatment arm |
Workman et al. | 1984 | no non-diet treatment arm |
Harries et al. | 1983 | adult population |
Riordan et al. | 1993 | adult population |
Matsumoto et al. | 2005 | no EN only comparator arm, adult population |
AZA, azathioprine; 5-ASA, mesalamine; EEN, exclusive enteral nutrition; EN, Enteral Nutrition; CS, corticosteroids